Application of EFT in Postmenopausal Women

NCT ID: NCT07065526

Last Updated: 2025-07-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

58 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-15

Study Completion Date

2024-09-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Objectives: This study was conducted to determine the effect of emotional liberation technique on sleep and quality of life in postmenopausal women.

Methods: The study was conducted as a randomized controlled trial with 58 women in a university hospital in Turkey. Of the women, 29 were in the intervention group and 29 were in the control group. Data were collected using the Personal Information Form, Subjective Experience Unit Scale (SUE), Pittsburg Sleep Quality Index (PSQI) and Menopause Specific Quality of Life Scale (MENQOL). EFT was applied to women in the intervention group four times at one-week intervals. The emotional liberation technique was applied to the women in the control group after the post-test was applied and the data were reported.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postmenopausal Sleep Quality of Life

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

EFT Group

Following the pre-test in the first encounter, the participants were administered the first EFT lasting 30-40 minutes by the first author, who is a certified EFT facilitator, followed by the CPS. Afterwards, a total of 4 sessions of EFT were administered at 1-week intervals. The CPS was applied before and after each EFT. After the last EFT session, SUE, PSQI and MENQOL post-tests were administered.

Group Type EXPERIMENTAL

Emodin

Intervention Type BEHAVIORAL

Following the pre-test in the first encounter, the participants were administered the first EFT lasting 30-40 minutes by the first author, who is a certified EFT facilitator, followed by the CPS. Afterwards, a total of 4 sessions of EFT were administered at 1-week intervals. The CPS was applied before and after each EFT. After the last EFT session, SUE, PSQI and MENQOL post-tests were administered.

Control group

Following the pre-test application, post-tests were applied 4 weeks later. They received routine treatment and care. The control group was taught EFT application after the study was completed.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Emodin

Following the pre-test in the first encounter, the participants were administered the first EFT lasting 30-40 minutes by the first author, who is a certified EFT facilitator, followed by the CPS. Afterwards, a total of 4 sessions of EFT were administered at 1-week intervals. The CPS was applied before and after each EFT. After the last EFT session, SUE, PSQI and MENQOL post-tests were administered.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Between 45 and 60 years old,
* No menstruation for at least 12 months
* A score of 5 or higher on the Pittsburgh Sleep Quality Index (PSQI)
* Conscious postmenopausal women who can read and write Turkish and have person, place, and time orientation

Exclusion Criteria

* Anyone with an intellectual disability or diagnosed psychiatric illness, anyone taking medications that may affect sleep patterns, anyone on hormone replacement therapy,
* People who have previously been trained in EFT and have communication problems.
Minimum Eligible Age

45 Years

Maximum Eligible Age

60 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

KTO Karatay University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Merve Yazar

PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

KTO Karatay University

Karatay, Konya, Turkey (Türkiye)

Site Status

Necmettin Erbakan Üniveristesi Tıp Fakültesi Hastanesi

Konya, Meram, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KTO Karatay University

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.